In 2018, the UK governing administration chose to allow the prescription of CBMPs in distinct circumstances, which was a major turning stage. This final decision brought about cannabis becoming rescheduled under the Misuse of Medication Restrictions being a “Routine two” drug.Insp Colin Norden stated: "On the outside, these two Qualities appear